Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-BCV in advanced solid tumors
NCT05747339Unknown
- Sponsor
- Wuxi People's Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Metabolically Activated Prodrugs
01
Overview
Open-label, single-arm trial of Neo-BCV in solid tumor, sponsored by Wuxi People's Hospital. Primary endpoint: Relief degree of tumors. Status: unknown.
02
Drugs
Neo-BCV
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05747339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05747339.